USANA Health Sciences, Inc.
USNA
$20.03
$0.231.16%
NYSE
| 09/27/2025 | 06/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.40% | -5.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.40% | -5.49% | |||
| Cost of Revenue | -2.73% | -4.31% | |||
| Gross Profit | -11.21% | -5.80% | |||
| SG&A Expenses | -3.15% | -6.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.05% | -6.30% | |||
| Operating Income | -92.68% | 6.68% | |||
| Income Before Tax | -90.47% | 12.41% | |||
| Income Tax Expenses | 0.99% | 12.40% | |||
| Earnings from Continuing Operations | -163.79% | 12.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 117.74% | -804.46% | |||
| Net Income | -167.55% | 2.69% | |||
| EBIT | -92.68% | 6.68% | |||
| EBITDA | -62.62% | 1.88% | |||
| EPS Basic | -168.36% | 5.65% | |||
| Normalized Basic EPS | -88.37% | 6.76% | |||
| EPS Diluted | -169.23% | 6.12% | |||
| Normalized Diluted EPS | -88.36% | 6.84% | |||
| Average Basic Shares Outstanding | -1.19% | -2.81% | |||
| Average Diluted Shares Outstanding | -1.31% | -2.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||